Tuesday, March 5, 2019

Investorideas.com - Report: Legal Marijuana Industry Employs Over 200,000 Full-Time Workers

Investorideas.com - Report: Legal Marijuana Industry Employs Over 200,000 Full-Time Workers

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Interview with Patrick Rea, CEO and CO-Founder of Canopy Boulder Inc.


Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Interview with Patrick Rea, CEO and CO-Founder of Canopy Boulder Inc.




Delta, Kelowna, BC –March 5, 2019 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast features an interview with Patrick Rea, CEO and CO-Founder of Canopy Boulder Inc. where we discuss some of the factors when deciding to invest in a cannabis company and what are some of the largest "pitfalls" investors should be wary of and why.



Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.  Learn more https://www.investorideas.com/membership/




About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication  services and costs https://www.investorideas.com/News-Upload/ 


Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411







#Cannabisstocks - Westleaf (TSXV: $WL.V) (OTCQB: $WSLFF) Begins Trading in the US on the #OTCQB Venture Market



#Cannabisstocks - Westleaf (TSXV: $WL.V) (OTCQB: $WSLFF) Begins Trading in the US on the #OTCQB Venture Market

Latest development in Company’s execution of strategy to provide additional channels for investors to participate

CALGARY, ALBERTA –March 5, 2019 – (Investorides.com Newswire) Westleaf Inc. (TSX-V: WL) (OTCQB:WSLFF) (“Westleaf”) is pleased to announce it has been approved to begin trading on the OTCQB effective immediately. Westleaf begins trading tomorrow under the symbol “WSLFF”. Investors can find real-time information on the Company and the trading statistics at www.otcmarkets.com. 


“We are excited to provide an additional channel for investors to participate in Westleaf by being available to the US market through the OTCQB,” noted Scott Hurd, President and CEO of Westleaf. “This comes at a time when we are executing on all aspects of our vertically integrated cannabis strategy, from cultivation, and extraction through to product formulation and retail distribution.”

Highlights:

·        Trading Under “WSLFF” on OTCQB: Westleaf will be trading under the symbol WSLFF and will be available immediately on the OTCQB;
·        Vertically Integrated Company: Westleaf is a Canadian vertically integrated cannabis company operating or developing assets for the Canadian medicinal and recreational cannabis marketplace;
·        Westleaf operates or is developing assets across the cannabis value chain, including:
o   Cultivation: A 130,000 square foot indoor cultivation facility in Saskatchewan under construction and expected to produce ~14,600 kg of flower per annum once both phases are completed (see assumptions in forward looking statements)
o   Extraction: A 60,000 square foot extraction and production facility in Alberta under construction, which is expected to produce a variety of derivative cannabis products, including tincture oil and gel caps (currently allowed under the Cannabis Act in Canada)
o   Distribution: Retail operations under the unique Prairie Records brand rolling out across Western Canada with plans to open up to 50 stores by the end of 2020.

Westleaf joins a growing list of Canadian companies that have chosen to trade on the OTCQB. The market provides companies with increased exposure to US and global investors interested in the cannabis space.  

About Westleaf Inc.

Westleaf is a vertically integrated cannabis company focused on innovative retail experiences and engaging cannabis brands as well as cultivation, production and extraction of cannabis products. Westleaf is rolling out a national retail footprint for its retail concept Prairie Records, with stores planned for British Columbia, Alberta, Saskatchewan and potentially Ontario. The retail concept leverages the instinctual tie between recreational cannabis and music and redefines the cannabis purchasing experience. The Company also has two significant production facilities under construction and scheduled for completion in 2019. For more information, please visit www.westleaf.com or www.prairierecords.ca.

More Information:
Bruce Leslie, VP Corporate Communications
403-801-7612

Or

Chelsea Smyth, North Strategic
403-616-4956

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release

Cautionary Statements

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. This news release, forward-looking statements relate, among other things, to: (i) the business and operations of Westleaf, including the implementation of Westleaf’s vertically integrated cannabis strategy; (ii) Westleaf’s cultivation facility in Saskatchewan currently under construction (the “Thunderchild facility”), including the development of the Thunderchild facility, the quality of the facility, the expected opening date thereof, and production estimates from the Thunderchild facility; (iii) Westleaf’s extraction and production facility in Alberta under construction, and (iv) Westleaf’s retail operations roll-out across Western Canada.  Such forward-looking statements are subject to certain assumptions that are reasonable in management’s view, including that the expected production numbers for the Thunderchild facility are based on 7,300 kg of cannabis flower in each of Phase I and Phase II of the Thunderchild cultivation facility, with Phase I consisting of the following: facility floor plate of approximately 65,550 square feet (~85,000 total square feet); Phase I and II each have grow/flower bench capacity of 21,000 square feet and assumes 60 grams per yield per square foot per harvest and 5.8 harvests per annum. Cultivation and sale of cannabis from the Thunderchild facility is subject to receipt of a license from Health Canada. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: timing and completion of the exterior and interior of Westleaf’s facilities under construction; completion of review of the facilities by Health Canada and receipt of a license from Health Canada; compliance with all conditions to draw down on the ATB Financial credit facilities of Westleaf; assumptions regarding facility size, yield and harvests at the facility; general business, economic, competitive, political and social uncertainties;. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Westleaf assume no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

This news is published on the Investorideas.com Newswire – News that Inspires big ideas

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp  Disclosure: this   news is a paid for news release on the Investorideas.com newswire by Westleaf Inc   Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

Marijuana / Hemp / Cannabis Stocks at Cannabisinvestorideas.com and Investorideas.com
    


Investorideas.com potcasts - Listen Daily to Investor Ideas Potcasts #Cannabis News and Stocks on the Move
Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Follow Pot stocks news - Get News Alerts on Marijuana Stocks








Monday, March 4, 2019

Investorideas.com - Melius Research Initiates Coverage of Cannabis Sector

Investorideas.com - Melius Research Initiates Coverage of Cannabis Sector

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: Harvest One (TSXV: HVT, OTCQX: HRVOF) Acquires Delivra to Strengthen its Medical and Wellness Division

Investorideas.com - #Cannabisstocks: Harvest One (TSXV: HVT, OTCQX: HRVOF) Acquires Delivra to Strengthen its Medical and Wellness Division

Investorideas.com - #Cannabisstocks: SOL Global (CSE: SOL) (OTCQB: SOLCF) Provides Update on Groundbreaking Achievement Made by Its European Strategic Investment European Cannabis Holdings

Investorideas.com - #Cannabisstocks: SOL Global (CSE: SOL) (OTCQB: SOLCF) Provides Update on Groundbreaking Achievement Made by Its European Strategic Investment European Cannabis Holdings

www.investorideas.com - news that inspires big ideas

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Aurora Cannabis (NYSE: $ACB) (TSX: $ACB.TO), Aphria (TSX; $APHA.TO)(NYSE: $APHA),The Hill Street Beverage Company (TSXV: $BEER.V) (OTC: $HSEEF), Zenabis Global (TSXV: $ZENA.V) and Canopy Growth (NYSE: $CGC) (TSX: $WEED.TO)


  
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Aurora Cannabis (NYSE: $ACB) (TSX: $ACB.TO), Aphria (TSX; $APHA.TO)(NYSE: $APHA),The Hill Street Beverage Company (TSXV: $BEER.V) (OTC: $HSEEF), Zenabis Global  (TSXV: $ZENA.V) and Canopy Growth  (NYSE: $CGC) (TSX: $WEED.TO)



Delta, Kelowna, BC –March 4, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we begin our “Monday Review” which will be focussing on a few early announcements as well as industry trends from the previous week. Today’s “Monday Review” features Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), Aphria Inc. (TSX; APHA)(NYSE: APHA),The Hill Street Beverage Company (TSXV: BEER) (OTC: HSEEF), Zenabis Global Inc. (TSXV: ZENA) and Canopy Growth Inc. (NYSE: CGC) (TSX:WEED).

Let’s start with the easy news of Aurora Cannabis Inc. announcing that the Company has completed the acquisition of all the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation, in an all-share transaction, pursuant to the terms of an amalgamation agreement dated January 31, 2019 among Whistler, Aurora, and a wholly owned subsidiary of Aurora.
Whistler has developed one of Canada's most iconic cannabis brands, built on quality, award-winning, organic certified BC bud and the transaction provides Aurora with a premium and differentiated organic certified product suite, expanding both its medical and consumer offerings, and reinforcing Aurora's presence in the well-established west coast cannabis market.

"Now that this transaction is complete, we intend to accelerate development of Whistler and leverage its iconic brand globally," said Terry Booth, CEO of Aurora. "Applying certain of our best practices to the Whistler cultivation protocols, we anticipate an increase in capacity of the Pemberton facility beyond the stated 5,000 kg annual production target. Furthermore, in pursuing EU GMP certification, we expect, once certified, to offer Whistler's premium organic flower and derivative products in the much higher margin EU medical cannabis market, further increasing the accretive nature of this transaction. Whistler and Aurora are very much aligned with respect to cannabis culture and community. We expect a swift and successful integration with Whistler, our latest partner."

Aurora has had a busy month. having announced the first commercial export of cannabis oil to the United Kingdom, the Company's construction of a 300,000 square foot expansion at the Edmonton International Airport, named Aurora Polaris, intended to serve as Aurora's centre of excellence for the industrial-scale production of higher margin, as well ast it has agreed to terms to acquire a 51% ownership interest in Gaia Pharm Lda., a license applicant in Portugal, to establish a local facility to produce medical cannabis and derivative products.

Aphria Inc. announced that Health Canada has granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the Company's completed Part IV and Part V expansions.

"This is a major milestone for Aphria on its path to becoming a leading global cannabis producer, as well as a positive development greatly anticipated by the Canadian cannabis industry," said Irwin D. Simon, Interim CEO of Aphria. "Aphria's progress expanding production and automation is essential to our strategy of securing scale and long-term advantages that enable the evolution of the cannabis industry through product and brand innovation. With Aphria One, we now have the ability to expand our production capacity by over three times."

Simon concluded, "We are ready to hit the ground running and look forward to alleviating industry-wide supply constraints with our greatly expanded production capacity and sophisticated, proprietary automation technology that will ensure Aphria remains at the forefront of cannabis cultivation and innovation. In anticipation of Health Canada's approval, we had allocated a portion of our previously approved capacity to mother and vegetative plants that will be used as the initial growing crops in Part IV and Part V. As a result of these measures, growing operations in the expanded facilities are expected to commence without delay. By this Friday, we will move swiftly to establish nearly 22,000 plants in the Part IV and Part V expansion, with an additional 12,000 plants added each week thereafter until we reach full crop rotation."

This follows Aphria Inc.’s announcement in February of a worldwide license agreement with Manna Molecular Science, LLC, as well as the independent members of its Board of Directors consisting of Shlomo Bibas, John Herhalt, Tom Looney and Irwin Simon, who unanimously approved the early termination and liquidation of a promissory note, option and other agreements related to the Company's previously announced divestment of all interests in Liberty Health Sciences, Inc.

As detailed on September 6, 2018, the Company entered into a share purchase agreement with a group of buyers, wherein it completed the sale of the shares making up 100% of its outstanding interest in Liberty, in exchange for a five-year promissory note due September 6, 2023, bearing interest at 12% per annum and in the amount of $59,097,986. Aphria retained an irrevocable option to repurchase its shares in Liberty from the buyers for a period of up to five years, subject to the satisfaction of certain conditions.

In line with Aphria's commitment to enhanced corporate governance practices and a renewed focus on its strategic plan, the option in the Liberty shares represented a non-essential holding of the Company. Accordingly, the independent members of the Board of Directors unanimously approved the Early Termination  and Liquidation  wherein the Company received  cash  consideration of $47.4 million and may earn up to an additional $10 million based on certain value thresholds, if the counterparties monetize the Liberty shares underlying the terminated option within six months. Jefferies LLC acted as financial advisor to the Company.

The Hill Street Beverage Company challenged Canadians to go alcohol-free for the month of January, and in doing so demonstrated its ability to leverage effective marketing to achieve its business objectives.

The "Hill Street Challenge" represented the Company's first fully-integrated marketing campaign, and capitalized on a growing trend to go "dry" for the month of January. It was designed to build awareness of the Hill Street brand amongst Canadians, help people understand the benefits of going alcohol-free, and ultimately drive consideration of the company's alcohol-free products.

This follows the announcement with Lexaria Bioscience Corp. to license Lexaria's DehydraTECHTM, on a semi-exclusive basis, for a term of five 5 years,  and a national agreement with Lifford Cannabis Solutions Inc. , who will be responsible for the sales and distribution of Hill Street's cannabis-infused beverage portfolio in Canada.

"We created the Hill Street Challenge as a way to highlight some benefits of going alcohol-free, but decided to do that in a slightly outrageous way so people would sit-up and take notice" said David Pullara, Chief Marketing Officer at Hill Street, referring to the irreverent videos created as part of the campaign. "We've been working hard over the past year to get people to understand that giving up alcohol doesn't mean giving up drinking or even having a good time, and the outstanding results of this campaign demonstrate our efforts are having an impact."

Zenabis Global Inc. announced that it has been approved to cultivate and grow cannabis at its 255,000 square foot facility in Stellarton, Nova Scotia. This represents the third Zenabis facility in Canada licensed to grow cannabis, adding design capacity of 18,500 kilograms of dried cannabis per year.

This follows Zenabis announcing reaching a letter of intent with the Société québécoise du cannabis (SQDC). Quebec is the ninth Canadian jurisdiction in which Zenabis has a distribution relationship. Zenabis also has distribution arrangements with government and third-party retailers/distributors in British Columbia, Alberta, Saskatchewan, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island, and the Yukon Territory.


Lastly we look at Canopy Growth Corporation who announced a transformative clinical research partnership that will investigate the efficacy of cannabinoids as an integral part of a novel treatment for post-concussion neurological diseases in former NHL players.

Researchers estimate that between 1.6 and 3.8 million athletes suffer from a sports-related concussion each year*. Ten to 15 percent of these athletes will go on to develop chronic post-concussion symptoms that can affect their ability to function. The results of this original study may also lead to new cannabinoid-based therapies that help athletes in other professional sports, along with adults who suffer from the aftermath of brain injuries from accidents and other activities.
         
Approximately 100 former players will be enrolled in this randomized double-blind study. The research will be led by NEEKA Health Canada's Dr. Amin Kassam, a world-renowned neurosurgeon who completed his undergraduate training at the University of Toronto and has led four neurosurgery programs over two decades. Joining Dr. Kassam is Dr. Richard Rovin, a neurosurgeon who completed post-graduate training through the Global Clinical Scholars Research Training Program at Harvard University Medical School. Their combined expertise in neuroscience, molecular cell signaling, brain mapping, and clinical trial design may lead to novel cannabis therapies that have the potential to improve the lives of patients suffering from post-concussion healthcare issues.

This follows a busy month for Canopy Growth Corporation having announced that Martha Stewart has joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories, naming Hilary Black as its Chief Advocacy Officer, and the multi-year agreement with Alimentation Couche-Tard Inc. (TSX: ATD.A) (TSX: ATD.B) in which, pending the results of a public-consultation process, Couche-Tard has entered into a trademark license agreement with one of the winners of the Alcohol and Gaming Commission of Ontario's Expression of Interest Application Lottery, who will operate a "Tweed" branded retail store in London, Ontario once the process is complete. The lottery winner will have full ownership and control over the London store.

As the cannabis industry continues to grow Investorideas.com “potcasts” will continue to deliver more ideas worth investing in.
         
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708



  Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.  Learn more https://www.investorideas.com/membership/




About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication  services and costs https://www.investorideas.com/News-Upload/ 
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411